News

Cerapedics, a medical device company, has completed a round of private equity financing totaling $15m. NGN Capital led the round and was joined by sole Series A investor

The National Institutes of Health has said it will consider research proposals comparing the cost-effectiveness of biologic medications, cancer treatments and preventive measures for chronic illnesses such as

Genta, a biopharmaceutical company, has completed patient enrollment in Agenda, a Phase III trial of Genasense injection in patients with advanced melanoma. Final accrual totaled 315 subjects. Agenda

PPD, a contract research organization, has acquired Magen BioSciences, a biotechnology company focused on dermatologic therapies based in Waltham, Massachusetts. Under the terms of the deal, PPD purchased

Dr Reddy’s and Natco would together develop these products for registration and global commercialization including regulated markets of the US and EU. Natco shall exclusively manufacture and supply

Besides enabling a fast and reliable analysis of 2D gel images, the new software called Redfin Solo allows researchers to decide which analyses are worth paying for based

Most recently, Mr Brisebois was assistant vice president of marketing and sales at Richardson International. Prior to joining Richardson, Mr Brisebois held various sales and marketing positions with

The Japanese Ministry of Health, Labor and Welfare has also granted approval for the Reliant stent graft balloon catheter, which is used in abdominal and thoracic endovascular procedures

Matthew Plavan, who has been serving as the company’s interim CEO since December 2008, has been named the company’s COO. Mr Plavan will also retain his executive vice